Bioventus Stock Probability of Future Stock Price Finishing Over 16.13

BVS Stock  USD 10.67  0.15  1.43%   
Bioventus' future price is the expected price of Bioventus instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Bioventus performance during a given time horizon utilizing its historical volatility. Check out Bioventus Backtesting, Bioventus Valuation, Bioventus Correlation, Bioventus Hype Analysis, Bioventus Volatility, Bioventus History as well as Bioventus Performance.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.
  
Price To Free Cash Flows Ratio is likely to gain to 43.43 in 2024, whereas Price To Sales Ratio is likely to drop 0.61 in 2024. Please specify Bioventus' target price for which you would like Bioventus odds to be computed.

Bioventus Target Price Odds to finish over 16.13

The tendency of Bioventus Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 16.13  or more in 90 days
 10.67 90 days 16.13 
near 1
Based on a normal probability distribution, the odds of Bioventus to move over $ 16.13  or more in 90 days from now is near 1 (This Bioventus probability density function shows the probability of Bioventus Stock to fall within a particular range of prices over 90 days) . Probability of Bioventus price to stay between its current price of $ 10.67  and $ 16.13  at the end of the 90-day period is more than 94.0 .
Considering the 90-day investment horizon Bioventus has a beta of 0.2 suggesting as returns on the market go up, Bioventus average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bioventus will be expected to be much smaller as well. Additionally Bioventus has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Bioventus Price Density   
       Price  

Predictive Modules for Bioventus

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bioventus. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioventus' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
7.0410.6714.30
Details
Intrinsic
Valuation
LowRealHigh
3.407.0311.74
Details
Naive
Forecast
LowNextHigh
5.849.4713.10
Details
3 Analysts
Consensus
LowTargetHigh
4.104.505.00
Details

Bioventus Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Bioventus is not an exception. The market had few large corrections towards the Bioventus' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bioventus, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bioventus within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.07
β
Beta against Dow Jones0.20
σ
Overall volatility
0.81
Ir
Information ratio -0.02

Bioventus Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bioventus for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bioventus can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Bioventus generated a negative expected return over the last 90 days
Bioventus has high historical volatility and very poor performance
Bioventus has high likelihood to experience some financial distress in the next 2 years
Bioventus has 394.85 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. Bioventus has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Bioventus to invest in growth at high rates of return.
The entity reported the last year's revenue of 512.35 M. Reported Net Loss for the year was (96.74 M) with profit before taxes, overhead, and interest of 302.71 M.
About 70.0% of Bioventus shares are held by institutions such as insurance companies
Latest headline from news.google.com: Bioventus Shares Gap Up - Heres Why - MarketBeat

Bioventus Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bioventus Stock often depends not only on the future outlook of the current and potential Bioventus' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bioventus' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding62.6 M
Cash And Short Term Investments37 M

Bioventus Technical Analysis

Bioventus' future price can be derived by breaking down and analyzing its technical indicators over time. Bioventus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bioventus. In general, you should focus on analyzing Bioventus Stock price patterns and their correlations with different microeconomic environments and drivers.

Bioventus Predictive Forecast Models

Bioventus' time-series forecasting models is one of many Bioventus' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bioventus' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Bioventus

Checking the ongoing alerts about Bioventus for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bioventus help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bioventus generated a negative expected return over the last 90 days
Bioventus has high historical volatility and very poor performance
Bioventus has high likelihood to experience some financial distress in the next 2 years
Bioventus has 394.85 M in debt with debt to equity (D/E) ratio of 1.17, which is OK given its current industry classification. Bioventus has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Bioventus to invest in growth at high rates of return.
The entity reported the last year's revenue of 512.35 M. Reported Net Loss for the year was (96.74 M) with profit before taxes, overhead, and interest of 302.71 M.
About 70.0% of Bioventus shares are held by institutions such as insurance companies
Latest headline from news.google.com: Bioventus Shares Gap Up - Heres Why - MarketBeat

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.